2. Radioimmunoassay
• Radioimmunoassay (RIA) involves the identification &
separation of a protein (from a mixture) using the
specificity of antibody - antigen binding and
quantification using radioactivity
• The technique was introduced in 1960 by Berson and
Yalow as an assay for the concentration of insulin in
plasma.
• It represented the first time that hormone levels in the
blood could be detected by an in vitro assay
3. The virtues of a good radioimmunoassay
• PRECISION : ≈ reproducibility; characterized by
low inter-assay and intra-assay variability. (Both values
need to be < 10%)
• ACCURACY : are the figures approaching the real
concentration? (Use an independent approach to verify
e.g. a physicochemical technique)
4. The virtues of a good radioimmunoassay
• SENSITIVITY : how little can still be
detected? (Can be enhanced by pre-incubating
the cold hormone with the Ab, prior to tracer
addition)
• SPECIFICITY : lack of cross-reaction with
related molecules. Dilution curves of samples
and standards need to be parallel!
5. Principle of Radioimmunoassay
• Principle: Uses an immune reaction [Antigen –
Antibody reaction] to estimate a ligand
Ag + Ag* + Ab AgAb + Ag*Ab + Ag + Ab*
– Unbound Ag* and Ag washed out
– Radioactivity of bound residue measured
– Ligand conc is inversely related to radioactivity
[Ag : ligand to be measured ; Ag* radiolabelled ligand]
6. Advantages of RIA
Highly specific: Immune reactions are
specific
High sensitivity : Immune reactions are
sensitive
Using antibodies of high affinity, it is possible
to detect a few picograms (10−12
g) of antigen
in the tube.
7. Disadvantages of RIA
Radiation hazards: Uses radiolabelled reagents
Requires specially trained persons
Labs require special license to handle radioactive
material
Requires special arrangements for
Requisition, storage of radioactive material
radioactive waste disposal.
8. Requirements for RIA
1. Preparation & characterisation of the
Antigen [Ligand to be analysed]
2. Radiolabelling of the Antigen
3. Preparation of the Specific Antibody
4. Development of Assay System
9. Preparation & Radiolabelling of the Antigen
• Antigens prepared by..
– Synthesis of the molecule
– Isolation from natural sources
• Radiolabelling [Tagging procedure]
– 3
H 14
C 125
I are used as radioactive tags
– Antigens are tagged to 3
H 14
C 125
I
– Tagging should NOT affect Antigenic
specificity & Antigenic activity !
10. Preparation of the Specific Antibody
• Antigen injected intradermally into rabbits or
guinea pigs antibody production
• Antibodies recovered from the serum
• Some ligands are not Antigenic
– Hormones, Steroids, Drugs HAPTENS
– Eg: Gastrin, Morphine,
– Haptens conjugated to albumin antigenic
11. Development of the Assay System
• A crucial step is separation of unbound antigens
• This achieved by binding the antibodies to the
microtitre well surface [Solid phase RIA]
• Antigens bound to the fixed antibodies remain
stuck to the inner surface
• Decanting & washing the well removes unbound
antigens
• Other techniques of separation: Centrifugation
12. Assay Procedure
• Add known amounts of the test sample + labelled antigen
into the microtitre wells
• Incubate allow the reaction to reach completion
• Decant & wash contents of the well removes all
unbound antigens
• Radioactivity remaining in the Microtitre wells measured by
a Counter [GM counter , Scintillation counter etc]
• Intensity of radioactivity is inversely correlated with the conc
of antigens in the test sample
• Sensitive to very low conc of antigens
14. From the data, a standard
binding curve, like them one
shown in red, can be drawn
The samples to be
assayed (the unknowns) are
run in parallel.
After determining the ratio
of bound to free antigen in
each unknown, the antigen
concentrations can be read
directly from the standard
curve.
21. Applications of Radioimmunoassays
• Endocrinology
– Insulin, HCG, Vasopressin
– Detects Endocrine Disorders
– Physiology of Endocrine Function
• Pharmacology
– Morphine
– Detect Drug Abuse or Drug Poisoning
– Study Drug Kinetics
22. Applications of Radioimmunoassays
• Epidemiology
– Hepatitis B
• Clinical Immunology
– Antibodies for Inhalant Allergens
– Allergy Diagnosis
• Oncology
– Carcinoembryonic Antigen
– Early Cancer Detection and Diagnosis
24. Enzyme Linked Immunosorbent Assay
• Principle:
– Uses an immune reaction like RIA
– Differs from RIA in detection method
– Detection based on
• Enzyme catalysed reaction OR
• Fluorescent probe
• NOT radioactivity [great advantage!]
25. Advantages of ELISA
• Sensitive: nanogram levels or lower
• Reproducible
• Minimal reagents
• Qualitative & Quantitative
– Qualitative Eg HIV testing
– quantitative assays Eg Ther. Drug Monitoring
• Greater scope : Wells can be coated with Antigens OR
Antibodies
• Suitable for automation high speed
• NO radiation hazards
26. Types of ELISA
1. Noncompetitive binding assay or Sandwich
method
1. Antigen measuring system [Titrewells coated with
antibodies ; Enzyme labelled antibodies]
2. Antibody measuring system [Titrewells coated with
antigens ; Enzyme labelled antiantibodies]
2. Competitive binding assay [Titrewells coated with
antibodies ; Enzyme labelled antigens]
27. Noncompetitive or Sandwich Assay
• Antigen measuring system
– Titre wells coated with suitable antibody
– Add patient sample containing the antigen
– Incubate: till antigen antibody reaction is complete
– Wash remove unbound antigen
– Add Antibody labelled with Enzyme
– Incubate till antigen binds labelled antibody
– Wash remove unbound labelled antibody
– Add substrate ; incubate
– Enzyme + Substrate Product measure colour
– Colour proportional to antigen in patient sample
28. Competitive binding assay
• Titrewells coated with antibodies
• Known quantities of patient sample containing antigen
+ antigen labelled with enzyme
• Incubate: till antigen antibody reaction is complete
• Wash remove unbound antigens
• Add substrate ; incubate
• Enzyme + Substrate Product measure colour
• Colour inversely related to antigen in patient sample
29. Enzyme labels
• Enzyme labels should have high specific reactivity
• Should be easily coupled to ligands & the labelled
complex must be stable
• The reactivity should be retained after linking of the
enzyme to the antigen/antibody
• The chosen enzymes should not be normally present in
the patient samples
• Examples of enzyme labels
– Horse radish peroxidase, Alkaline phosphatase, Glucose
oxidase
30. Applications of ELISA
• Analysis of hormones, vitamins, metabolites, diagnostic
markers
– Eg. ACTH, FSH, T3, T4, Glucagon, Insulin, Testosterone,
vitamin B12, prostaglandins, glucocorticoids,
• Therapeutic drug monitoring:
– Barbiturates, morphine, digoxin,
• Diagnostic procedures for detecting infection
– HIV, Hepatitis A, B etc